Below are the financial statements of Kalbe Farma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in trillions of IDR | 2024 | 2023 |
|---|---|---|
| Net sales | 32.63a | 30.45a |
| Cost of goods sold | -19.67a | -18.63a |
| Gross profit | 12.96a | 11.82a |
| Selling expenses | -6.81a | -6.3a |
| General and administrative expenses | -1.51a | -1.5a |
| Research and development expenses | -0.47a | -0.33a |
| Other operating income | 0.05a | 0.06a |
| Other operating expenses | -0.13a | -0.16a |
| Interest income | 0.18a | 0.09a |
| Interest expense and financial charges | -0.07a | -0.1a |
| Share in gain of the associates, net | 0.03a | 0.03a |
| Income before income tax expense | 4.22a | 3.61a |
| Income tax expense | -0.97a | -0.83a |
| Income for the year | 3.25a | 2.78a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Kalbe Farma’s data sources below and access millions more through our Disclosure Search.